Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3/4 comparison of artesunate-pyronaridine and artemisinin-naphthoquine versus artemether-lumefantrine for malaria in Papua New Guinean children
ACTRN12610000913077Phase 4Completed
- Sponsor
- The University of Western Australia
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pyronaridine, naphthoquine and artemether + lumefantrine in malaria and Malaria (3 arms), sponsored by The University of Western Australia. Started Apr 2012; status: completed.
02
Drugs
pyronaridinenaphthoquineartemether + lumefantrine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12610000913077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000913077.